| 发明名称 |
Pyridoxamine for the Treatment of Diabetic Kidney Disease |
| 摘要 |
The present invention provides pharmaceutical compositions comprising dosage units of pyridoxamine, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier, and methods for their use in limiting the progression of renal disease and/or diabetic complications in human diabetic patient. |
| 申请公布号 |
US2014171472(A1) |
申请公布日期 |
2014.06.19 |
| 申请号 |
US201414185312 |
申请日期 |
2014.02.20 |
| 申请人 |
NephroGenex, Inc. |
发明人 |
Degenhardt Thorsten;Schotzinger Robert;Fox J. Wesley |
| 分类号 |
A61K31/44;A61K45/06 |
主分类号 |
A61K31/44 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition comprising:
(a) a dosage unit of 50 mg to 500 mg of pyridoxamine, or a pharmaceutically acceptable salt thereof; and (b) a pharmaceutically acceptable carrier.
|
| 地址 |
Princeton NJ US |
